News

Is there a chance of similar legislation in the United States?

Post-licensure safety data on recombinant zoster vaccine (Shingrix) is consistent with pre-licensure clinical trial data, although the CDC cautions that the immunization is still in the “early uptake period.”

Japanese researchers find a concerning resistance to a new antiviral flu medication.

In an ongoing study spanning more than 15 years, investigators have made key discoveries about how HIV and TB drugs affect pregnant and postpartum women, leading to new safety and dosing recommendations for several medications.

The FDA has accepted an NDA for imipenem/cilastatin/relebactam as well as a supplemental NDA for ceftolozane/tazobactam.

Rutgers University investigators created a pictorial key that anyone with a strong enough microscope can use to correctly identify the Asian longhorned tick from other harmless species.

Whole-genome sequencing could speed up targeted treatment for patients infected with antibiotic-resistant bacteria, a proof of concept study by Johns Hopkins investigators determined.

Hospital visits for so-called “Victorian-era” diseases are on the rise in the United Kingdom, and experts there believe public health budget cuts may be behind the upswing.

Taking pre-exposure prophylaxis does not appear to lower the quality of life for people at risk of contracting HIV.

We’ve rounded up a list of important US Food and Drug Administration (FDA) and US Department of Agriculture (USDA) recalls from this past week.

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

In 2016, 60% of adolescents had initiated the HPV vaccine series but only 16% completed the vaccination series by age 13 and 35% by age 15.

The US Preventive Services Task Force evaluated existing recommendations and reaffirmed that newborns should receive ocular antibiotic ointment at birth to prevent gonococcal ophthalmia neonatorum.

SCYNEXIS has announced results from the first interim analysis of the phase 3 FURI study evaluating oral ibrexafungerp for invasive fungal infections.

A next-generation phenotyping system is seeking to revolutionize antibiotic susceptibility testing in an effort to begin treating patients faster and to combat antibiotic resistance.

Basophils play a critical role in inducing immune responses against infections and could potentially play a part in preventing the development of sepsis.

Investigators compared an antibiotic monotherapy and a combination therapy for MSSA bacteremia and found that both had similar results, raising the call for new treatment options.

Patients who believe themselves to be at a high risk of contracting HIV are more likely to accept pre-exposure prophylaxis (PrEP) than their peers. That’s one key finding from a new study that looked at how individual factors affect PrEP uptake.

Investigators have detected the presence of Ebola in a bat in Liberia, revealing more about how bats serve as reservoirs for the deadly pathogen.

Merck has received a Breakthrough Therapy Designation for investigational 15-valent pneumococcal conjugate vaccine V114.

New research has suggested that Alzheimer disease pathology may be driven by an infectious agent, Porphyromonas gingivalis.

Health system continues to lead the way in stewardship; hopefully more will follow.

A new analysis sheds light on what is needed to hit this benchmark.

Thomas Lodise, PharmD, PhD, explains the economic burden of community-acquired pneumonia as well as the associated risks that accompany currently available treatment options.

A new study identifies several easy-to-adopt strategies that can help individuals to remember to take PrEP at roughly the same time every day.

TAK-003, being developed by Takeda, is a tetravalent vaccine based on a live-attenuated dengue serotype 2 virus, which provides the genetic “backbone” for all 4 virus serotypes.

A new guideline on the management of gonorrhea has been issued by the British Association for Sexual Health and HIV.

Investigators followed a pediatric cohort in Nicaragua over the course of 15 years and found that dengue fever immunity offers some protection against symptomatic Zika disease.